Y200-3330 Screening compound: 2-(2,3-dihydro-1,4-benzodioxin-6-yl)-4-(morpholine-4-carbonyl)quinoline

Y200-3330 Screening compound: 2-(2,3-dihydro-1,4-benzodioxin-6-yl)-4-(morpholine-4-carbonyl)quinoline
Y200-3330 Screening compound: 2-(2,3-dihydro-1,4-benzodioxin-6-yl)-4-(morpholine-4-carbonyl)quinoline alternative view

Chemical Structure Depiction of ChemDiv screening compound Y200-3330
2-(2,3-dihydro-1,4-benzodioxin-6-yl)-4-(morpholine-4-carbonyl)quinoline

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y200-3330

Molecular Formula

C22H20N2O4 (C22 H20 N2 O4)

Compound Name

2-(2,3-dihydro-1,4-benzodioxin-6-yl)-4-(morpholine-4-carbonyl)quinoline

IUPAC name

2-(23-dihydro-14-benzodioxin-6-yl)-4-(morpholine-4-carbonyl)quinoline

SMILES

O=C(c1cc(-c(cc2)cc3c2OCCO3)nc2ccccc12)N1CCOCC1

InChI

InChI=1S/C22H20N2O4/c25-22(24-7-9-26-10-8-24)17-14-19(23-18-4-2-1-3-16(17)18)15-5-6-20-21(13-15)28-12-11-27-20/h1-6,13-14H,7-12H2

InChI Key

KTUVMEFCMSKNSY-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD04055629

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

376.41

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

3.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

2.561

Distribution Coefficient, logD

2.557

Water Solubility, LogSw

-3.11

Polar Surface Area

48.678

Acid Dissociation Constant (pKa)

28.46

Base Dissociation Constant (pKb)

5.36

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

27.30

Y200-3330 in Drug Discovery

Included in Screening Libraries

Anti-Aging Library (44940 compounds)

Antimitotic Tubulin Library (17355 compounds)

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

PI3K-Targeted Library (17255 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Metabolic
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Mechanism of action:
  • Epigenetic
  • Receptor's ligands
Targets:
  • GPCR
  • Kinases

References: we are preparing a list of scientific research reports with Y200-3330 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y200-3330?
Check Price and Availability of Y200-3330, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y200-3330 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y200-3330
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y200-3330
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y200-3330 available by request